[home]
[thesaurus]
Click Here to return To Results
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011
See this aricle in Pubmed
Article Abstract
No abstract available for this article
Related Tags
(click to filter results - removes previous filter)
adverse drug reaction
asymptomatic
complications
creatine phosphokinase(CPK)elevated
drug interactions
iatrogenic neurologic disorders
muscle pain
myopathy
rhabdomyolysis
risk factors
risk-benefit assessment
safety
simvastatin
statin therapy
statin therapy,discontinuation
statin therapy,dose
symptomatic
Click Here to return To Results